GlassScriptPhysician profile
Imran A Mirza
NPI 1376573204
$1,158.24
in general payments reported to CMS, 2019-2025
17 companies · $56.43 in 2025
The $56.43 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.38 · 2020: $111 · 2021: $113 · 2022: $302 · 2023: $369 · 2024: $168 · 2025: $56.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $328.00 | 2019-2022 | |
| Glaxosmithkline, LLC. | $156.39 | 2021-2023 | Bexsero, Pediarix |
| Merck Sharp & Dohme LLC | $110.70 | 2022-2023 | Verquvo, Segluromet, Steglujan |
| Teva Pharmaceuticals USA, INC. | $88.71 | 2023-2024 | Austedo Xr |
| Novartis Pharmaceuticals Corporation | $87.44 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $80.89 | 2022-2024 | Abilify Mycite, Nuedexta |
| Abbvie INC. | $52.50 | 2022-2025 | |
| Pfizer INC. | $45.71 | 2023 | |
| Cranial Technologies, INC | $39.76 | 2022-2023 | Doc Band |
| Amgen INC. | $31.48 | 2024 | Repatha |
| Vanda Pharmaceuticals INC. | $29.96 | 2022-2023 | Hetlioz, Fanapt |
| Electromed, INC. | $28.76 | 2023 | Smartvest |
| Ucb, INC. | $18.27 | 2024 | Briviact |
| Acadia Pharmaceuticals INC | $17.72 | 2025 | Nuplazid |
| Optinose US, INC. | $14.75 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $13.69 | 2023 | Gvoke Hypopen |
| E.R. Squibb & Sons, L.L.C. | $13.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Mirza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.